IP Library Granted Patent US 12,129,482
Granted Patent B2
US 12,129,482 · App. 17/383,279 · Granted Oct 29, 2024

Methods for generating, evaluating, gene editing and cloning pluripotent stem cells comprising a lethal haplotype

Inventors: David Kendall (Beloit, WI); Diego Moreno (Navasota, TX)
Assignee: INGURAN, LLC
C12N5/0606C12N2501/115C12N2501/415C12N2501/727C12N2502/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,129,482
App. No.
17/383,279
Granted
Oct 29, 2024
Kind
B2
Abstract

The invention includes a method of evaluating a bovine embryo by fertilizing an egg obtained from a first bovine heterozygote of a recessive lethal haplotype with sperm cells obtained from a second bovine heterozygote of the recessive lethal haplotype; producing the embryo from the fertilized egg, wherein the embryo is homozygous for the lethal haplotype; establishing a cell culture from the embryo; collecting a plurality of cultured cells; and obtaining omics data, comprising one or more features, from the plurality of cultured cells.

Claims (25)

1. A method of evaluating a bovine embryo comprising:

fertilizing an egg obtained from a first bovine heterozygote of a recessive lethal haplotype with sperm cells obtained from a second bovine heterozygote of the recessive lethal haplotype;

producing the embryo from the fertilized egg, wherein the embryo is homozygous for the lethal haplotype;

establishing a stem cell culture from the embryo;

collecting a plurality of cultured stem cells; and

obtaining omics data, comprising one or more features, from the plurality of cultured stem cells.

2. The method of claim 1 , wherein the recessive lethal haplotype is selected from the group consisting of: AH1, HH1, HH2, HH3, HH4, HH5, HH6, JH1, JH2, BH1 and BH2.

3. The method of claim 1 , wherein the step of establishing a cell culture from the embryo comprises culturing the embryo at the blastocyst stage.

4. The method of claim 1 , wherein the omics data is comprised of genotypic, proteomic or transcriptomic data.

5. The method of claim 1 , wherein the step of establishing a cell culture comprises placing the embryo, or a cell sample from the embryo, on a first substrate in a first culture media comprising a low free-fatty acid BSA (bovine serum albumin), Fibroblast Growth Factor 2 and an inhibitor of Wnt signaling for 5-15 days and thereafter dissociating cell outgrowths on the first substrate and placing the cell outgrowths on a second substrate in a second culture media comprising a ROCK (Rho-associated coiled-coil containing kinase) inhibitor.

6. The method of claim 5 , wherein the first substrate and the second substrate are comprised of irradiated mouse embryonic fibroblasts.

7. The method of claim 5 , wherein the cell sample from the embryo comprises cells from the inner cell mass of the embryo.

8. A method of evaluating a plurality of bovine embryos comprising:

fertilizing a plurality of eggs obtained from one or more female bovine heterozygotes of a recessive lethal haplotype with sperm cells obtained from one or more male bovine heterozygotes of the recessive lethal haplotype;

producing the plurality of embryos from the plurality of fertilized eggs, wherein the embryos are homozygous for the lethal haplotype;

identifying a first group of one or more embryos from the plurality of embryos that are underdeveloped or dead after a first period of time;

establishing a stem cell culture from each of the embryos in the identified first group;

collecting cultured stem cells from each of the established stem cell cultures; and

obtaining omics data from the collected cultured stem cells.

9. The method of claim 8 , wherein the omics data comprises one or more features.

10. The method of claim 8 , further comprising the steps of:

identifying a second group of one or more embryos from the plurality of embryos that are underdeveloped or dead after a second period of time; and

obtaining omics data from the identified second group.

11. The method of claim 10 , wherein the omics data is comprised of genotypic, proteomic or transcriptomic data.

12. The method of claim 8 , wherein the recessive lethal haplotype is selected from the group consisting of: AH1, HH1, HH2, HH3, HH4, HH5, HH6, JH1, JH2, BH1 and BH2.

Assignments (2)
SECURITY INTEREST Recorded Nov 24, 2025
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073783/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2021
From: KENDALL, DAVID; MORENO, DIEGO
To: INGURAN, LLC
Reel/Frame 057707/0182 →
Continuity (2)
Provisional Application 63056386 · Jul 24, 2020
Related Publication 20220025323A1 · Jan 27, 2022